Month: October 2022

To be cost-effective compared with metformin for initial therapy for type 2 diabetes, prices for a sodium-glucose cotransporter-2 (SGLT2) inhibitor or a glucagon-like peptide-1 (GLP-1) agonist would have to fall by at least 70% and at least 90%, respectively, according to estimates. The study, modeled on US patients, by Jin G. Choi, MD, and colleagues, was
0 Comments
New liver stiffness (LS) thresholds offer accurate prediction of disease progression and clinical outcomes in patients with nonalcoholic steatohepatitis (NASH) and advanced fibrosis, according to investigators. These new LS thresholds are more reliable because they are based on high-quality prospective data drawn from four randomized controlled trials, reported lead author Rohit Loomba, MD, of the
0 Comments
Joint flexibility is an important measure of physical fitness in humans, especially when it comes to determining athletic performance. It is responsible for protecting the muscle-tendon unit under stressful conditions by resisting external forces for long periods of time and ensuring a wider range of motion (RoM) of the joints. Joint stiffness of the lower
0 Comments
New Report: Type 1 Diabetes is More Difficult and Dangerous for Girls – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2022 Everyday Health, Inc. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be used by
0 Comments
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. Market still oversold When to buy chip Quick mentions: TJX, DIS, ABBV 1. Market still oversold We’re finally saying goodbye to September — but likely not to all the volatility
0 Comments
A study led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the “la Caixa” Foundation, has found that exposure to phthalates in the womb is associated with reduced lung function during childhood. The findings of the study, published in Environmental Pollution, support the European Union’s current restrictions on the use of
0 Comments
Suicide risk was higher in people recently diagnosed with dementia, especially younger patients, a case-control study in England showed. Compared with people who didn’t have dementia, suicides rose in people who received a dementia diagnosis in the past 3 months (adjusted OR 2.47, 95% CI 1.49-4.09), according to Danah Alothman, BMBCh, MPH, of the University
0 Comments
Every time an individual refreshes their social media feed, they encounter typical “gym bros.” They see gym junkies flexing their muscles and drinking their protein. Recently, a new gym culture has emerged on social media that entails uploading transformation pictures, comparing bodies, and adhering to trends in order to be accepted in fitness centers. In
0 Comments
Men who have sex with men (MSM) living with HIV, especially those who are young or who’ve had gonorrhea should get the human papillomavirus (HPV) 9-valent vaccine (Gardasil 9), findings of a newly published study in JAIDS suggests. According to the World Health Organization, only 30% of the target population worldwide has received the HPV
0 Comments
Efficacy of the investigational drug lebrikizumab is maintained in patients with moderate to severe atopic dermatitis for at least 1 year, according to new results from the phase 3 ADvocate1 and ADvocate2 trials. “We’re focused on the responders,” said Andrew Blauvelt, MD, MBA, as he presented the positive findings at the European Academy of Dermatology
0 Comments
Using advanced diffusion neuroimaging technology, Kessler Foundation researchers investigated the relationship between the rate of cognitive fatigue to microstructural changes in the brain in persons with multiple sclerosis. Their findings help fill a gap in the current understanding of how brain pathology influences the development of fatigue over time. Their findings were reported in Frontiers
0 Comments
Scientists are still trying to understand why many breast cancer survivors experience troubling cognitive problems for years after treatment. Inflammation is one possible culprit. A new long-term study of older breast cancer survivors published today in the Journal of Clinical Oncology and co-led by UCLA researchers adds important evidence to that potential link. Higher levels
0 Comments